Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993022priorityCriticalpatent/ECSP993022A/en
Publication of ECSP993022ApublicationCriticalpatent/ECSP993022A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Las 5-aril-2,4 -tiazolidindionas son potentes agonistas de PPAR y, por lo tanto, son útiles en el tratamiento, control o prevención de la diabetes, hiperglicemia, hiperlipidemia (incluyendo hipercolesterolemia e hipertrigliceridemia), arterosclerosis, obesidad, restenosis vascular y otras enfermedades, desórdenes y condiciones mediadas por PARR(( (y/o (5-Aryl-2,4-thiazolidinediones are potent PPAR agonists and therefore useful in the treatment, control, or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis and other PARR-mediated diseases, disorders and conditions (((and / or (
DERIVATIVES OF 5-ARIL-2,4-TIAZOLIDINDIONA, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
Use of a composition comprising a glucosamine salt or a glucosamine derivative for the manufacture of a medicament for the treatment of human thrombosis